Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-12-11

Clinical Trial Update: Varenicline Adjunctive Treatment in Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 trial update on varenicline as an adjunctive treatment in schizophrenia and related disorders completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Varenicline (varenicline)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED | Results posted: 2017-12-11